September 24, 2017 5:59 AM ET

Pharmaceuticals

Company Overview of Silvergate Pharmaceuticals, Inc.

Company Overview

Silvergate Pharmaceuticals, Inc. develops and commercializes pediatric medications. The company markets its products under the Epaned brand name. Silvergate Pharmaceuticals, Inc. was incorporated in 2010 and is based in Greenwood Village, Colorado.

6251 Greenwood Plaza Boulevard

Suite 101

Greenwood Village, CO 80111

United States

Founded in 2010

Phone:

855-379-0382

Key Executives for Silvergate Pharmaceuticals, Inc.

Chief Executive Officer
Compensation as of Fiscal Year 2017.

Silvergate Pharmaceuticals, Inc. Key Developments

Silvergate Pharmaceuticals, Inc. Announces Xatmep™ (methotrexate) Oral Solution

Silvergate Pharmaceuticals, Inc. announced that Xatmep™ (methotrexate) Oral Solution, the first and only FDA-approved methotrexate oral solution, is now available for ordering. Xatmep is indicated for the treatment of acute lymphoblastic leukemia (ALL) and the management of polyarticular juvenile idiopathic arthritis (pJIA) in pediatric patients. Xatmep (methotrexate) Oral Solution, 2.5 mg/mL, is a ready-to-use product that requires no preparation, facilitating ease of dispensing at the pharmacy. Xatmep is manufactured under CGMPs in accordance with FDA regulations. It eliminates the need for needles, crushing or splitting tablets, or compounding tablets into a liquid formulation. It requires refrigeration, but may be stored at room temperature for 60 days after dispensing to the patient. Xatmep will be available through an extensive network of pharmacies. Xatmep is a folate analog metabolic inhibitor indicated for the: treatment of pediatric patients with acute lymphoblastic leukemia (ALL) as part of a multi-phase, combination chemotherapy maintenance regimen an dmanagement of pediatric patients with active polyarticular juvenile idiopathic arthritis (pJIA) who have had an insufficient therapeutic response to, or are intolerant of, an adequate trial of first-line therapy including full-dose non-steroidal anti-inflammatory agents (NSAIDs).

FDA Approves XATMEP™, the First and Only Ready-To-Use Methotrexate Oral Solution

Silvergate Pharmaceuticals, Inc. announced that the United States Food and Drug Administration (FDA) approved XATMEP (methotrexate) Oral Solution, the first and only FDA-approved methotrexate oral solution. XATMEP is indicated for the treatment of acute lymphoblastic leukemia (ALL) and polyarticular juvenile idiopathic arthritis (pJIA) in pediatric patients. XATMEP (methotrexate) Oral Solution, 2.5 mg/mL, is a ready-to-use product that requires no preparation, facilitating accuracy and ease of dispensing at the pharmacy. XATMEP is manufactured under CGMPs in accordance with FDA regulations. It eliminates the need for needles, crushing or splitting tablets or for compounding tablets into a liquid formulation. It requires refrigeration but may be stored at room temperature for 60 days after dispensing. XATMEP is available through an extensive network of pharmacies and a qualified mail-order service.

Silvergate Pharmaceuticals, Inc. Announces Availability of EPANED Oral Solution

Silvergate Pharmaceuticals, Inc. announced that EPANED® Oral Solution, the first and only FDA-approved enalapril oral solution, is now available for ordering. EPANED is an oral solution that enables consistent weight-based dosing for children over 1 month of age. EPANED reduces the potential for errors as a ready-to-use solution that does not require mixing. EPANED is indicated for the treatment of hypertension (high blood pressure) in adult and pediatric patients older than 1 month of age, treatment of symptomatic heart failure, and treatment of asymptomatic left ventricular dysfunction.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Silvergate Pharmaceuticals, Inc., please visit www.silvergatepharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.